[1]
“The effect of interleukin-2 on natural killer activity of bone marrow and peripheral stem cell products from non-hodgkin’s lymphoma patients ”, Ann Med Res , vol. 3, no. 3, pp. 0177–0182, May 2021, Accessed: Oct. 15, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/2529